GGrantIndex
← Leaderboards

John C Newman

University Of California, San Francisco

$10,570,507
Attributed
$13,705,069
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY201425
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,705,069 · 7

By mechanism

R01$9,664,412 · 3
RF1$2,039,697 · 1
K08$971,849 · 1
R25$874,806 · 1
T35$154,305 · 1

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposAgingMolecularKetone BodiesMetabolismFastingKetogenic DietBrainMetabolicLinkBeta-HydroxybutyrateMouse ModelGerosciencePathway InteractionsInnovationInflammationIn VivoBiological MarkersSignal TransductionBiologyFunctional DisorderPhenotypeSmall MoleculeKetones

Grant awards (30)

TAKEOFF: Targeting Aging with Ketone Ester in Older adults for Function in Frailty$2,039,697
RF1 · FY2025 · AG · contact PI
UCLA Medical Student Training in Aging Research (MSTAR) Program$154,305
T35 · FY2025 · AG
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium$766,837
R01 · FY2024 · AG · contact PI
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain$758,000
R01 · FY2024 · AG · contact PI
TAKEOFF: Targeting Aging with Ketone Ester in Older adults for Function in Frailty$702,825
R01 · FY2024 · AG · contact PI
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium$115,399
R01 · FY2024 · AG · contact PI
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium$67,316
R01 · FY2024 · AG · contact PI
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium$769,087
R01 · FY2023 · AG · contact PI
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain$758,000
R01 · FY2023 · AG · contact PI
TAKEOFF: Targeting Aging with Ketone Ester in Older adults for Function in Frailty$755,249
R01 · FY2023 · AG · contact PI
Geroscience Education and Training (GET) Network$289,647
R25 · FY2023 · AG
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain$45,072
R01 · FY2023 · AG · contact PI
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium$769,087
R01 · FY2022 · AG · contact PI
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain$758,000
R01 · FY2022 · AG · contact PI
Geroscience Education and Training (GET) Network$266,862
R25 · FY2022 · AG
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain$108,174
R01 · FY2022 · AG · contact PI
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium$71,785
R01 · FY2022 · AG · contact PI
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain$63,102
R01 · FY2022 · AG · contact PI
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium$38,441
R01 · FY2022 · AG · contact PI
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium$769,087
R01 · FY2021 · AG · contact PI
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain$758,000
R01 · FY2021 · AG · contact PI
Geroscience Education and Training (GET) Network$318,297
R25 · FY2021 · AG
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium$809,451
R01 · FY2020 · AG · contact PI
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain$781,500
R01 · FY2020 · AG · contact PI
Epigenetic regulation of healthspan and longevity by ketone bodies$162,800
K08 · FY2018 · AG · contact PI
Epigenetic regulation of healthspan and longevity by ketone bodies$157,849
K08 · FY2018 · AG · contact PI
Epigenetic regulation of healthspan and longevity by ketone bodies$162,800
K08 · FY2017 · AG · contact PI
Epigenetic regulation of healthspan and longevity by ketone bodies$162,800
K08 · FY2016 · AG · contact PI
Epigenetic regulation of healthspan and longevity by ketone bodies$162,800
K08 · FY2015 · AG · contact PI
Epigenetic regulation of healthspan and longevity by ketone bodies$162,800
K08 · FY2014 · AG · contact PI